Fintel reports that on January 28, 2025, BTIG initiated coverage of Arcturus Therapeutics Holdings (NasdaqGM:ARCT) with a Buy recommendation. Analyst Price Forecast Suggests 331.48% Upside As of ...

Providing a diverse range of perspectives from bullish to bearish, 5 analysts have published ratings on Arcturus Therapeutics ARCT in the last three months. The table below summarizes their recent ...

REI President and CEO Eric Artz will retire this spring, the co-op announced Wednesday. Artz took over as CEO in 2019, leading REI through the boom and bust that affected the outdoor retail market ...

SEATTLE, Jan. 22, 2025 /PRNewswire/ -- REI Co-op president & CEO, Eric Artz, today announced that he will retire in March as CEO, marking a new chapter in the co-op's 87-year history. Mary Beth ...

© 2024 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and ...

REI CEO Eric Artz is retiring at the end of March, the Issaquah-based co-op announced Wednesday. Artz joined the company in 2012 as its chief financial officer after two decades of working for ...

Weeks after the retailer shuttered its experiences business, REI on Wednesday announced that CEO Eric Artz will retire in March as part of a planned succession process. Mary Beth Laughton ...

ARCT has been the subject of a number of research reports. HC Wainwright reaffirmed a “buy” rating and issued a $63.00 price objective on shares of Arcturus Therapeutics in a research note on ...